Department of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Suite 2.42D, Pittsburgh, Pennsylvania 15213, USA.
EMBO Rep. 2010 Apr;11(4):299-304. doi: 10.1038/embor.2010.18. Epub 2010 Mar 12.
Eukaryotic translation initiation factor 4E (eIF4E) is the cap-binding protein that binds the 5' cap structure of cellular messenger RNAs (mRNAs). Despite the obligatory role of eIF4E in cap-dependent mRNA translation, how the translation activity of eIF4E is controlled remains largely undefined. Here, we report that mammalian eIF4E is regulated by SUMO1 (small ubiquitin-related modifier 1) conjugation. eIF4E sumoylation promotes the formation of the active eIF4F translation initiation complex and induces the translation of a subset of proteins that are essential for cell proliferation and preventing apoptosis. Furthermore, disruption of eIF4E sumoylation inhibits eIF4E-dependent protein translation and abrogates the oncogenic and antiapoptotic functions associated with eIF4E. These data indicate that sumoylation is a new fundamental regulatory mechanism of protein synthesis. Our findings suggest further that eIF4E sumoylation might be important in promoting human cancers.
真核翻译起始因子 4E(eIF4E)是结合细胞信使 RNA(mRNA)5'帽结构的帽结合蛋白。尽管 eIF4E 在依赖帽的 mRNA 翻译中具有必需作用,但 eIF4E 的翻译活性如何受到控制在很大程度上仍未确定。在这里,我们报告哺乳动物 eIF4E 受 SUMO1(小泛素相关修饰物 1)缀合的调节。eIF4E 的 SUMO 化促进了活性 eIF4F 翻译起始复合物的形成,并诱导了一组对细胞增殖和防止细胞凋亡至关重要的蛋白质的翻译。此外,破坏 eIF4E 的 SUMO 化会抑制 eIF4E 依赖性蛋白质翻译,并消除与 eIF4E 相关的致癌和抗细胞凋亡功能。这些数据表明 SUMO 化是蛋白质合成的一个新的基本调节机制。我们的研究结果进一步表明,eIF4E 的 SUMO 化可能在促进人类癌症中起重要作用。